Paper41005308
Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens.
Zhou RW and 10 others. Cell, 2025. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens. Papers, record 41005308. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41005308
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Tumor-Associated, Carbohydrate | Major topic |
| Immunotherapy | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Polysaccharides | |
| Tumor Microenvironment | |
| T-Lymphocytes | |
| Cell Line, Tumor | |
| Female | |
| Immunosuppression Therapy | |
| Lectins |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| UM1 TR004927 | NCATS NIH HHS | United States | UM1TR004927 | PubMed | NIH RePORTER |
| U01 CA233078 | NCI NIH HHS | United States | U01CA233078 | PubMed and NIH | NIH RePORTER |
| R41 CA233111 | NCI NIH HHS | United States | R41CA233111 | PubMed and NIH | NIH RePORTER |
| TL1 TR001875 | NCATS NIH HHS | United States | TL1TR001875 | PubMed and NIH | NIH RePORTER |
| P30 CA062203 | NCI NIH HHS | United States | P30CA062203 | PubMed and NIH | NIH RePORTER |
| UL1 TR001873 | NCATS NIH HHS | United States | UL1TR001873 | PubMed | NIH RePORTER |
| R42 CA285234 | NCI NIH HHS | United States | R42CA285234 | PubMed and NIH | NIH RePORTER |
| R41 CA261408 | NCI NIH HHS | United States | R41CA261408 | PubMed and NIH | NIH RePORTER |
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14184143 | THE TREATMENT OF APLASTIC ANAEMIA WITH PHYTOHAEMAGGLUTININ. | Lancet | 1964 | https://conductscience.org/library/papers/14184143 | PubMed |
| 2 | 23054969 | Stratification of antibody-positive subjects by antibody level reveals an impact of immunogenicity on pharmacokinetics. | AAPS J | 2013 | https://conductscience.org/library/papers/23054969 | PubMed |
| 3 | 15879151 | Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. | J Immunol | 2005 | https://conductscience.org/library/papers/15879151 | PubMed |
| 4 | 24046919 | An update on the GLOB blood group system and collection. | Immunohematology | 2013 | https://conductscience.org/library/papers/24046919 | PubMed |
| 5 | 22531918 | Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation. | Eur J Immunol | 2012 | https://conductscience.org/library/papers/22531918 | PubMed |
| 6 | 34484225 | Co-Stimulatory Bispecific Antibodies Induce Enhanced T Cell Activation and Tumor Cell Killing in Breast Cancer Models. | Front Immunol | 2021 | https://conductscience.org/library/papers/34484225 | PubMed |
| 7 | 15837749 | Beta1,6-branched oligosaccharides are increased in lymph node metastases and predict poor outcome in breast carcinoma. | Clin Cancer Res | 2005 | https://conductscience.org/library/papers/15837749 | PubMed |
| 8 | 22143985 | Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells. | Glycobiology | 2012 | https://conductscience.org/library/papers/22143985 | PubMed |
| 9 | 16998493 | Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45. | Nat Immunol | 2006 | https://conductscience.org/library/papers/16998493 | PubMed |
| 10 | 29045792 | Glycopeptides as Targets for Dendritic Cells: Exploring MUC1 Glycopeptides Binding Profile toward Macrophage Galactose-Type Lectin (MGL) Orthologs. | J Med Chem | 2017 | https://conductscience.org/library/papers/29045792 | PubMed |
| 11 | 25324212 | Delineating binding modes of Gal/GalNAc and structural elements of the molecular recognition of tumor-associated mucin glycopeptides by the human macrophage galactose-type lectin. | Chemistry | 2014 | https://conductscience.org/library/papers/25324212 | PubMed |
| 12 | 13955674 | In vivo action of phytohaemagglutinin in severe human aplastic anemia. | Nature | 1963 | https://conductscience.org/library/papers/13955674 | PubMed |
| 13 | 5168456 | The effects of intravenous phytohaemagglutinin in a patient with disseminated malignant melanoma: a clinical and immunological study. | Rev Eur Etud Clin Biol | 1971 | https://conductscience.org/library/papers/5168456 | PubMed |
| 14 | 853039 | Biological and biochemical properties of Phaseolus vulgaris isolectins. | J Biol Chem | 1977 | https://conductscience.org/library/papers/853039 | PubMed |
| 15 | 15459394 | Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. | Science | 2004 | https://conductscience.org/library/papers/15459394 | PubMed |
| 16 | 10700233 | Suppression of tumor growth and metastasis in Mgat5-deficient mice. | Nat Med | 2000 | https://conductscience.org/library/papers/10700233 | PubMed |
| 17 | 26172302 | MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients. | Oncotarget | 2015 | https://conductscience.org/library/papers/26172302 | PubMed |
| 18 | 11918084 | Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis. | Clin Exp Metastasis | 2002 | https://conductscience.org/library/papers/11918084 | PubMed |
| 19 | 14224054 | PHYTOHAEMAGGLUTININ IN APLASTIC ANAEMIA. | Lancet | 1964 | https://conductscience.org/library/papers/14224054 | PubMed |
| 20 | 27269286 | Golgi self-correction generates bioequivalent glycans to preserve cellular homeostasis. | Elife | 2016 | https://conductscience.org/library/papers/27269286 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42964319 | A Modular Polysaccharide Platform With Tannic Acid-Driven van der Waals Lock-In for Programmable Protein Delivery. | Smart Med | 2026 | https://conductscience.org/library/papers/42964319 | PubMed |
| 42891405 | A lectin-directed antibody-recruiting molecule against Tn antigen for cancer immunotherapy. | RSC Adv | 2026 | https://conductscience.org/library/papers/42891405 | PubMed |
| 42840183 | The Five-Decade Journey of Small Cell Lung Cancer. | Cancer Commun (Lond) | 2026 | https://conductscience.org/library/papers/42840183 | PubMed |
| 42764979 | Biomaterial engineering of the tumor glycocalyx for cancer immunotherapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42764979 | PubMed |
| 42562812 | Post-translational modifications in metabolic reprogramming: implications for metabolic therapy and immunotherapy in cancer. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42562812 | PubMed |
| 42504977 | Using Synthetic Glycans to Investigate Anti-Glycan Antibodies and Explore Their Medical Potential. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/42504977 | PubMed |
| 42465518 | Spatial Glyco-Codes Define Human Liver Pathology and Progression. | bioRxiv | 2026 | https://conductscience.org/library/papers/42465518 | PubMed |
| 42457945 | Immune implications and therapeutic opportunities of tumor glycosylation. | Nat Cancer | 2026 | https://conductscience.org/library/papers/42457945 | PubMed |
| 42193932 | The Organoid Decade: Leveraging 3D Patient-Derived Organoids to Bridge the Translational Gap in Triple-Negative Breast Cancer: A Systematic Review. | Cells | 2026 | https://conductscience.org/library/papers/42193932 | PubMed |
| 42045937 | DHX37 and tumor growth: a novel avenue for melanoma research. | J Transl Med | 2026 | https://conductscience.org/library/papers/42045937 | PubMed |
| 42032105 | Organoid: a promising solution to current challenges in cancer immunotherapy. | NPJ Biomed Innov | 2025 | https://conductscience.org/library/papers/42032105 | PubMed |
| 41696681 | From Lock-and-Key to Velcro: Glycan-Dependent T Cell Recruiter Redefines Cancer Cell Targeting With Density-Dependent Recognition. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/41696681 | PubMed |
| 41486933 | Integrative perspectives on glycosylation networks in fungi and oomycetes. | J Microbiol | 2025 | https://conductscience.org/library/papers/41486933 | PubMed |
| 41478862 | Double trouble for the tumour glycocode. | Nat Rev Cancer | 2026 | https://conductscience.org/library/papers/41478862 | PubMed |
| 41152449 | Lectin-based bispecific targets tumour-associated glycans. | Nat Rev Drug Discov | 2025 | https://conductscience.org/library/papers/41152449 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41005308
GET https://conductscience.org/api/papers/v1/41005308/references?page=2